4-[3-(2,5-Dichloro-4,6-dimethyl-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-2-methoxy-6-nitrophenol, 98%, 25mg

2,2-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)acetonitrile, 97%, 100mg

Thalidomide-NH-C6-NH2 (TFA), 500mg

Cesium nitrate, ROTI®METIC 99.999% (5N), 50 g, plastic packaging.

Methyl 5-fluoro-1H-indole-2-carboxylate, 95.0%, 5g

3-Iodo-6-methylquinoline, 100mg

2,3-Difluorophenol, 98.0%, 25g

alpha-D-Lactose monohydrate, 95.0%, 250g

(R)-8-(Benzyloxy)-5-(2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)quinolin-2(1H)-one, 98%, 1g

4-(HYDROXYAMINO)-4-OXOBUTANOIC ACID, 95%, 250mg

2-(4-Hydroxyphenyl)isoindoline-1,3-dione, 98%, 1g

4-Chloro-[1,2,4]triazolo[4,3-a]quinoxaline, 95+%, 1g

9,10-Dimethoxy-6,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinoline, 100mg